When evaluating stage II CRC patients separately, SLPI expression was not associated with disease-free survival (HRR 1.48, P-value 0.19, 95% confidence interval 0.81–2.69, Fig. 2a). This evidence concerns the gene SLPI and colorectal carcinoma.